Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in J Exp Med

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    November 2021
  1. RAPPE JCF, Finsterbusch K, Crotta S, Mack M, et al
    A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    October 2021
  2. DECKER T
    The early interferon catches the SARS-CoV-2.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  3. LOPEZ J, Mommert M, Mouton W, Pizzorno A, et al
    Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    September 2021
  4. AHN M, Wang LF
    Translation from bats to humans beyond infectious diseases.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    August 2021
  5. CHEEMARLA NR, Watkins TA, Mihaylova VT, Wang B, et al
    Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  6. WILK AJ, Lee MJ, Wei B, Parks B, et al
    Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    July 2021
  7. BASTARD P, Orlova E, Sozaeva L, Levy R, et al
    Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  8. SOLFOROSI L, Kuipers H, Jongeneelen M, Rosendahl Huber SK, et al
    Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    June 2021
  9. LANZ C, Schotsaert M, Magnus C, Karakus U, et al
    IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  10. SANCHO-SHIMIZU V, Brodin P, Cobat A, Biggs CM, et al
    SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
    J Exp Med. 2021;218.
    PubMed     Abstract available


    May 2021
  11. ANDREANO E, Rappuoli R
    Immunodominant antibody germlines in COVID-19.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  12. LE BERT N, Clapham HE, Tan AT, Chia WN, et al
    Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  13. MERAD M, Vabret N
    Highlights from a year in a pandemic.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  14. BAUM A, Kyratsous CA
    SARS-CoV-2 spike therapeutic antibodies in the age of variants.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  15. KEDL RM
    Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    April 2021
  16. ZHUANG Z, Lai X, Sun J, Chen Z, et al
    Mapping and role of T cell response in SARS-CoV-2-infected mice.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  17. ONODI F, Bonnet-Madin L, Meertens L, Karpf L, et al
    SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  18. BRETON G, Mendoza P, Hagglof T, Oliveira TY, et al
    Persistent cellular immunity to SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  19. BASTARD P, Michailidis E, Hoffmann HH, Chbihi M, et al
    Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  20. POON MML, Farber DL
    Lasting memories of SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  21. MCCARTY NA
    Breathe-Your immune system is counting on it.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    March 2021
  22. SCHAFER A, Muecksch F, Lorenzi JCC, Leist SR, et al
    Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  23. LU Y, Jiang R, Freyn AW, Wang J, et al
    CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  24. RODRIGUES TS, de Sa KSG, Ishimoto AY, Becerra A, et al
    Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  25. BRYANT C
    COVID-19 stokes inflammasomes.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  26. SONG E, Zhang C, Israelow B, Lu-Culligan A, et al
    Neuroinvasion of SARS-CoV-2 in human and mouse brain.
    J Exp Med. 2021;218.
    PubMed     Abstract available


  27. NIMMERJAHN F, Ravetch JV
    Four keys to unlock IgG.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    January 2021
  28. PAIK DH, Farber DL
    Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity.
    J Exp Med. 2021;218.
    PubMed     Abstract available


    December 2020
  29. ISRAELOW B, Song E, Mao T, Lu P, et al
    Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  30. JOUAN Y, Guillon A, Gonzalez L, Perez Y, et al
    Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  31. VERAS FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, et al
    SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  32. RADERMECKER C, Detrembleur N, Guiot J, Cavalier E, et al
    Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  33. MAJOR J, Wack A
    An ace model for SARS-CoV-2 infection.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  34. KOAY HF, Fulford TS, Godfrey DI
    An unconventional view of COVID-19 T cell immunity.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    November 2020
  35. SCHMIDT F, Weisblum Y, Muecksch F, Hoffmann HH, et al
    Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  36. SHUBINA M, Tummers B, Boyd DF, Zhang T, et al
    Necroptosis restricts influenza A virus as a stand-alone cell death mechanism.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  37. KIM JH
    SARS-CoV-2 vaccine development, access, and equity.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    October 2020
  38. CASSOTTA A, Paparoditis P, Geiger R, Mettu RR, et al
    Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  39. ZHOU T, Su TT, Mudianto T, Wang J, et al
    Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    September 2020
  40. KOENIG LM, Boehmer DFR, Metzger P, Schnurr M, et al
    Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  41. NATHAN C
    Neutrophils and COVID-19: Nots, NETs, and knots.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  42. FREEDMAN TS, Headley MB, Serwas N, Ruhland M, et al
    Lessons of COVID-19: A roadmap for post-pandemic science.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  43. HOUSTON S
    Lessons of COVID-19: Virtual conferences.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    August 2020
  44. STOLLEY JM, Johnston TS, Soerens AG, Beura LK, et al
    Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  45. DIAMOND B
    The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    June 2020
  46. BARNES BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, et al
    Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  47. VARDHANA SA, Wolchok JD
    The many faces of the anti-COVID immune response.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    May 2020
  48. NATHAN CF, Nussenzweig MC, Pulvirenti T
    We are here for you and ready to hear from you.
    J Exp Med. 2020;217.
    PubMed    


  49. WEISS SR
    Forty years with coronaviruses.
    J Exp Med. 2020;217.
    PubMed     Abstract available


  50. PROKUNINA-OLSSON L, Alphonse N, Dickenson RE, Durbin JE, et al
    COVID-19 and emerging viral infections: The case for interferon lambda.
    J Exp Med. 2020;217.
    PubMed     Abstract available


    June 2019
  51. LIM HK, Huang SXL, Chen J, Kerner G, et al
    Severe influenza pneumonitis in children with inherited TLR3 deficiency.
    J Exp Med. 2019 Jun 19. pii: jem.20181621. doi: 10.1084/jem.20181621.
    PubMed     Abstract available


    January 2019
  52. KOSIK I, Angeletti D, Gibbs JS, Angel M, et al
    Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.
    J Exp Med. 2019 Jan 25. pii: jem.20181624. doi: 10.1084/jem.20181624.
    PubMed     Abstract available


    August 2018
  53. HERNANDEZ N, Melki I, Jing H, Habib T, et al
    Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.
    J Exp Med. 2018 Aug 24. pii: jem.20180628. doi: 10.1084/jem.20180628.
    PubMed     Abstract available


    February 2018
  54. LYNCH JP, Werder RB, Loh Z, Sikder MAA, et al
    Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion.
    J Exp Med. 2018;215:537-557.
    PubMed     Abstract available


    July 2017
  55. LAMBORN IT, Jing H, Zhang Y, Drutman SB, et al
    Recurrent rhinovirus infections in a child with inherited MDA5 deficiency.
    J Exp Med. 2017;214:1949-1972.
    PubMed     Abstract available


    June 2017
  56. KESAVARDHANA S, Kuriakose T, Guy CS, Samir P, et al
    ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death.
    J Exp Med. 2017 Jun 20. pii: jem.20170550. doi: 10.1084/jem.20170550.
    PubMed     Abstract available


    April 2017
  57. DEEG CM, Hassan E, Mutz P, Rheinemann L, et al
    In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein.
    J Exp Med. 2017 Apr 10. pii: jem.20161033. doi: 10.1084/jem.20161033.
    PubMed     Abstract available


    February 2017
  58. FU B, Wang L, Li S, Dorf ME, et al
    ZMPSTE24 defends against influenza and other pathogenic viruses.
    J Exp Med. 2017 Feb 28. pii: jem.20161270. doi: 10.1084/jem.20161270.
    PubMed     Abstract available


    January 2017
  59. GLENN JD, Smith MD, Xue P, Chan-Li Y, et al
    CNS-targeted autoimmunity leads to increased influenza mortality in mice.
    J Exp Med. 2017 Jan 5. pii: jem.20160517. doi: 10.1084/jem.20160517.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: